Weill Cornell Medicine receives third consecutive HEED award for diversity and inclusion

For the third year in a row, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, in recognition of its outstanding commitment to diversity and inclusion. INSIGHT Into Diversity, the largest and oldest diversity-focused publication in higher education, plans to highlight the winners…

Details

CODA appendicitis trial shows risks and benefits of treating appendicitis with antibiotics

Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from the Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) Trial reported today in the New England Journal of Medicine. The findings indicated that antibiotics were not worse than surgery when measuring overall health status, allowing most people…

Details

‘Like a fishing net,’ nanonet collapses to trap drug molecules

EVANSTON, Ill. — Northwestern University researchers are casting a net for nanoparticles. The team has discovered a new, rapid method for fabricating nanoparticles from a simple, self-assembling polymer. The novel method presents new possibilities for diverse applications, including water purification, diagnostics and rapidly generating vaccine formulations, which typically require many different types of molecules to…

Details

COVID-19 transmission rebounds quickly after physical distancing rules are relaxed

BOSTON – Across the U.S., the relaxation of statewide physical distancing measures that are designed to control the COVID-19 pandemic frequently resulted in an immediate reversal of public health gains against SARS-CoV-2, the virus that causes the disease, researchers from Massachusetts General Hospital (MGH) and colleagues reported. Looking at data from all 50 states and…

Details

TGen, Avery Therapeutics partnership studies engineered heart tissue’s mechanism of action

PHOENIX and TUCSON, Ariz. — Oct. 5, 2020 — Avery Therapeutics Inc. of Tucson has developed an engineered heart tissue, a lab-grown cardiac membrane that can help heal the heart, either following a heart attack or as a result of progressive heart disease. The heart tissue, called MyCardia™, could revolutionize the treatment of cardiovascular disease,…

Details

TCT Connect agenda now available

WHAT: The TCT Connect agenda is now available online at https://www.tctconnect.com/tct-full-program. TCT, the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place online October 14-18. Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the globe to present…

Details